CardioNet, Inc. Appoints New Chief Financial Officer
January 15 2010 - 4:14PM
Business Wire
CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical
technology company with an initial focus on the diagnosis and
monitoring of cardiac arrhythmias, announced today that Heather C.
Getz has been appointed to the position of Senior Vice President
and Chief Financial Officer, effective immediately. Ms. Getz, who
was previously Vice President of Finance at CardioNet, succeeds
Marty P. Galvan, who left the Company to pursue other career
opportunities.
Randy Thurman, Chairman, President and Chief Executive Officer
of CardioNet, stated, “We are pleased to welcome Heather into her
new role as Chief Financial Officer of CardioNet. I have known and
worked with Heather for eight years and I have complete confidence
in her financial leadership as we continue to implement our
reorganization plan and reduce expenses following the unexpected
reduction in Medicare reimbursement. She played an instrumental
role in planning our recent restructuring activities and possesses
a deep understanding of our business and financial systems, which
will insure a smooth transition to her new position. In addition,
Heather has a proven track record with relevant healthcare industry
experience that will be a valuable asset as we continue to expand
the market for CardioNet’s MCOT™ technology.”
Prior to joining CardioNet in May 2009, Ms. Getz was Vice
President of Finance at Alita Pharmaceuticals, a privately held
specialty pharmaceutical company. Ms. Getz has also held several
financial management positions at VIASYS Healthcare and Sunoco,
Inc. Ms. Getz is a Certified Public Accountant and received an MBA
and BS in accountancy from Villanova University.
Ms. Getz commented, “I am excited to have the opportunity to
expand my role at CardioNet. We are making significant progress in
reducing the Company’s expenses and improving the efficiency of our
operations, putting us on track to realize $15 million of expense
reductions in addition to the $8 million already achieved. Our
newly implemented electronic billing system and consolidated
reimbursement department are delivering improved collections. I
look forward to seeing these programs to fruition and believe that
as they are achieved, CardioNet will be in an excellent position to
benefit from the rapid adoption of our MCOT™ system.”
Mr. Thurman concluded, “Marty Galvan has been an important
member of the CardioNet executive team, particularly in guiding the
Company from private to public ownership during a high growth
period for the business. The Board of Directors and I would like to
thank Marty for his contributions to the Company and wish him well
in the future.”
About CardioNet
CardioNet is the leading provider of ambulatory, continuous,
real-time outpatient management solutions for monitoring relevant
and timely clinical information regarding an individual's health.
CardioNet's initial efforts are focused on the diagnosis and
monitoring of cardiac arrhythmias, or heart rhythm disorders, with
a solution that it markets as Mobile Cardiac Outpatient TelemetryTM
(MCOT™). More information can be found at
http://www.cardionet.com.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024